These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28455950)

  • 21. KSHV-encoded viral interferon regulatory factor 4 (vIRF4) interacts with IRF7 and inhibits interferon alpha production.
    Hwang SW; Kim D; Jung JU; Lee HR
    Biochem Biophys Res Commun; 2017 May; 486(3):700-705. PubMed ID: 28342865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of the viral interferon regulatory factors of KSHV for their requisite for virus production and inhibition of the type I interferon pathway.
    Golas G; Jang SJ; Naik NG; Alonso JD; Papp B; Toth Z
    Virology; 2020 Feb; 541():160-173. PubMed ID: 32056714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of growth signalling and cell cycle by Kaposi's sarcoma-associated herpesvirus genes.
    Direkze S; Laman H
    Int J Exp Pathol; 2004 Dec; 85(6):305-19. PubMed ID: 15566428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The viral interferon regulatory factors of kaposi's sarcoma-associated herpesvirus differ in their inhibition of interferon activation mediated by toll-like receptor 3.
    Jacobs SR; Gregory SM; West JA; Wollish AC; Bennett CL; Blackbourn DJ; Heise MT; Damania B
    J Virol; 2013 Jan; 87(2):798-806. PubMed ID: 23115281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence and genomic analysis of a Rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.
    Searles RP; Bergquam EP; Axthelm MK; Wong SW
    J Virol; 1999 Apr; 73(4):3040-53. PubMed ID: 10074154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus.
    Aresté C; Blackbourn DJ
    Trends Microbiol; 2009 Mar; 17(3):119-29. PubMed ID: 19230674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The viral interferon regulatory factors of KSHV: immunosuppressors or oncogenes?
    Jacobs SR; Damania B
    Front Immunol; 2011; 2():19. PubMed ID: 22566809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biology and oncogenicity of the Kaposi sarcoma herpesvirus K1 protein.
    Sousa-Squiavinato AC; Silvestre RN; Elgui De Oliveira D
    Rev Med Virol; 2015 Sep; 25(5):273-85. PubMed ID: 26192396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4/K10) is a novel interaction partner of CSL/CBF1, the major downstream effector of Notch signaling.
    Heinzelmann K; Scholz BA; Nowak A; Fossum E; Kremmer E; Haas J; Frank R; Kempkes B
    J Virol; 2010 Dec; 84(23):12255-64. PubMed ID: 20861242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pleiotropic effects of Kaposi's sarcoma herpesvirus.
    Schulz TF
    J Pathol; 2006 Jan; 208(2):187-98. PubMed ID: 16362980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-Wide Transcriptional Roles of KSHV Viral Interferon Regulatory Factors in Oral Epithelial Cells.
    Jang SJ; Atyeo N; Mietzsch M; Chae MY; McKenna R; Toth Z; Papp B
    Viruses; 2024 May; 16(6):. PubMed ID: 38932139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
    Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y
    Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays.
    Jenner RG; AlbĂ  MM; Boshoff C; Kellam P
    J Virol; 2001 Jan; 75(2):891-902. PubMed ID: 11134302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
    Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
    Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral interferon regulatory factors decrease the induction of type I and type II interferon during rhesus macaque rhadinovirus infection.
    Robinson BA; Estep RD; Messaoudi I; Rogers KS; Wong SW
    J Virol; 2012 Feb; 86(4):2197-211. PubMed ID: 22156526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
    Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H
    J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of interferon regulatory factor 5 activities by the Kaposi sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3 contributes to immune evasion and lytic induction.
    Bi X; Yang L; Mancl ME; Barnes BJ
    J Interferon Cytokine Res; 2011 Apr; 31(4):373-82. PubMed ID: 21133648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays.
    Dittmer DP
    Cancer Res; 2003 May; 63(9):2010-5. PubMed ID: 12727810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression.
    Shin YC; Joo CH; Gack MU; Lee HR; Jung JU
    Cancer Res; 2008 Mar; 68(6):1751-9. PubMed ID: 18339855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral interferon regulatory factors are critical for delay of the host immune response against rhesus macaque rhadinovirus infection.
    Robinson BA; O'Connor MA; Li H; Engelmann F; Poland B; Grant R; DeFilippis V; Estep RD; Axthelm MK; Messaoudi I; Wong SW
    J Virol; 2012 Mar; 86(5):2769-79. PubMed ID: 22171275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.